STAT News first reported about Prasad’s departure, saying it came after a number of controversial decisions by the FDA regarding a gene therapy drug.
Related Posts
Here are Tuesday’s biggest analyst calls: Nvidia, Apple, Tesla, Citi, CVS, American Express, Amazon, Kroger & more
Here are the biggest calls on Wall Street on Tuesday.
Zelenskyy hits back at Trump’s comments, says Ukraine is not for sale
The pugnacious response followed Trump’s suggestion that Ukraine was responsible for Russia’s invasion three years ago.
Tide owner Procter & Gamble cuts earnings, revenue outlook as quarterly sales disappoint
Procter & Gamble’s quarterly earnings topped estimates, but its revenue fell short of expectations.